FDA to Review Easing Restrictions on Peptide Drugs
Originally on
Bloomberg Podcasts · hosted by David Gura & Christina Ruffini
The guest
Amanda Mull
Bloomberg Businessweek senior reporter
Bloomberg Businessweek's Amanda Mull on the FDA's review of peptide-drug restrictions.
In this episode
- The PCAC summer 2026 meeting
- RFK Jr.'s reclassification push
- Category 2 → Category 1
- The black-market valuation
Listen & watch
Keep listening